ES2104163T3 - Liponucleotidos de seco-nucleosidos, su preparacion al igual que su utilizacion como medicamentos antiviricos. - Google Patents

Liponucleotidos de seco-nucleosidos, su preparacion al igual que su utilizacion como medicamentos antiviricos.

Info

Publication number
ES2104163T3
ES2104163T3 ES93917764T ES93917764T ES2104163T3 ES 2104163 T3 ES2104163 T3 ES 2104163T3 ES 93917764 T ES93917764 T ES 93917764T ES 93917764 T ES93917764 T ES 93917764T ES 2104163 T3 ES2104163 T3 ES 2104163T3
Authority
ES
Spain
Prior art keywords
well
antiviric
liponucleotides
seco
nucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93917764T
Other languages
English (en)
Spanish (es)
Inventor
Harald Zilch
Dieter Herrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2104163T3 publication Critical patent/ES2104163T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES93917764T 1992-08-08 1993-08-06 Liponucleotidos de seco-nucleosidos, su preparacion al igual que su utilizacion como medicamentos antiviricos. Expired - Lifetime ES2104163T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226279A DE4226279A1 (de) 1992-08-08 1992-08-08 Liponucleotide von Seco-Nucleosiden, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel

Publications (1)

Publication Number Publication Date
ES2104163T3 true ES2104163T3 (es) 1997-10-01

Family

ID=6465143

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93917764T Expired - Lifetime ES2104163T3 (es) 1992-08-08 1993-08-06 Liponucleotidos de seco-nucleosidos, su preparacion al igual que su utilizacion como medicamentos antiviricos.

Country Status (20)

Country Link
EP (1) EP0654036B1 (enExample)
JP (1) JP3479299B2 (enExample)
KR (1) KR100243440B1 (enExample)
CN (1) CN1040984C (enExample)
AT (1) ATE152114T1 (enExample)
AU (1) AU672994B2 (enExample)
CA (1) CA2141030A1 (enExample)
DE (2) DE4226279A1 (enExample)
DK (1) DK0654036T3 (enExample)
ES (1) ES2104163T3 (enExample)
FI (1) FI109699B (enExample)
GR (1) GR3023960T3 (enExample)
HU (1) HUT72605A (enExample)
IL (1) IL106588A (enExample)
MX (1) MX9304676A (enExample)
NO (1) NO304986B1 (enExample)
NZ (1) NZ254813A (enExample)
TW (1) TW306924B (enExample)
WO (1) WO1994003465A1 (enExample)
ZA (1) ZA935718B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
DE4402492A1 (de) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern
US7517858B1 (en) * 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
KR100389558B1 (ko) * 2000-10-11 2003-06-27 주식회사 한스환경엔지니어링 유리섬유 강화플라스틱 성형품의 표면처리용 직물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel

Also Published As

Publication number Publication date
AU4708293A (en) 1994-03-03
TW306924B (enExample) 1997-06-01
NZ254813A (en) 1996-05-28
GR3023960T3 (en) 1997-09-30
JPH08500345A (ja) 1996-01-16
WO1994003465A1 (de) 1994-02-17
KR950702998A (ko) 1995-08-23
ZA935718B (en) 1995-02-06
DE59306286D1 (de) 1997-05-28
AU672994B2 (en) 1996-10-24
DK0654036T3 (da) 1997-11-03
IL106588A0 (en) 1993-12-08
FI950533A0 (fi) 1995-02-07
CN1085908A (zh) 1994-04-27
JP3479299B2 (ja) 2003-12-15
FI950533L (fi) 1995-02-07
MX9304676A (es) 1994-03-31
DE4226279A1 (de) 1994-02-10
FI109699B (fi) 2002-09-30
NO950445L (no) 1995-02-07
HU9500374D0 (en) 1995-03-28
IL106588A (en) 1998-01-04
CN1040984C (zh) 1998-12-02
NO950445D0 (no) 1995-02-07
EP0654036A1 (de) 1995-05-24
CA2141030A1 (en) 1994-02-09
NO304986B1 (no) 1999-03-15
ATE152114T1 (de) 1997-05-15
KR100243440B1 (ko) 2000-03-02
HUT72605A (en) 1996-05-28
EP0654036B1 (de) 1997-04-23

Similar Documents

Publication Publication Date Title
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2032016T3 (es) Un procedimiento para la produccion de las 13, 14-ceto-pgfs.
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2089301T3 (es) Formulaciones analogas de lh-rh.
ES2188586T3 (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento para la profilaxis y terapia de enfermedades inflamatorias intestinales y de la piel, asi como purpura.
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ES2093440T3 (es) Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos.
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2088445T3 (es) Tabletas masticables de sucralfato.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2038289T3 (es) Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
FR2415103A1 (fr) Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2078130T3 (es) Nuevos derivados 2-ciano-3-hidroxi-propenamidas, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
HN2001000002A (es) PIRAZOLO [4,3-e] DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN, SU USO COMO PRODUCTOS MEDICINALES Y PROCESOS PARA PREPARARLAS.
ES2049280T3 (es) Utilizacion de un extracto seco de las hojas de ginkgo contra metastasis.
ES2062782T3 (es) Capsula oleaginosa de cetoprofeno.
NO950445D0 (no) Liponukleotider av sekonukleosider, deres fremstilling og deres anvendelse som antiviruslegemidler
ES2054822T3 (es) Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 654036

Country of ref document: ES